Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of Post-intubation Hyperdynamic Responses with Single-dose vs Split-dose Propofol plus Fentanyl
TCTR20260708007Phase 3Not yet recruiting
- Sponsor
- N/A
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of propofol, sponsored by N/A. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
propofol
Beyond the preview
Go deeper on TCTR20260708007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20260708007.